Group 1 - The company plans to publicly issue 50.01 million shares, accounting for 12.50% of the total share capital after issuance [1] - The strategic placement plan will participate in the subscription of up to 10% of the public offering scale, which is 5.01 million shares, with a total subscription amount not exceeding 50 million yuan [1] - The company is an international enterprise group specializing in the research, innovation, and industrialization of dietary nutritional supplements [1] Group 2 - The company's net profit attributable to the parent company for the years 2022 to 2024 is projected to be 142 million yuan, 160 million yuan, and 174 million yuan respectively [2] - The company expects a year-on-year revenue growth of approximately 15.03% to 27.36% for the first half of 2025, with net profit growth of about 8.56% to 19.20% [2] - The total planned investment for fundraising is approximately 603 million yuan, allocated to various projects including the construction of a nutritional health raw material production base and the expansion of production lines [2]

Group 1 - Suzhou Dingjia Precision Technology Co., Ltd. is set to hold an IPO review on April 7, 2025, focusing on the design, research, production, and sales of functional and protective products for consumer electronics [3] - The company reported revenues of 329 million yuan, 367 million yuan, and 408 million yuan for the years 2022 to 2024, with net profits of 53.57 million yuan, 51.94 million yuan, and 59.55 million yuan respectively, indicating a year-on-year revenue growth but a 3.03% decline in net profit for 2023 [3] - The company plans to raise 303 million yuan to expand production capacity from 624 million to 2.25 billion units, a growth of over 260%, although there are concerns regarding the rationality of this expansion due to declining capacity utilization [3] Group 2 - Jiyuan Group Co., Ltd. is an international enterprise group specializing in the research, innovation, and industrialization of dietary nutritional supplements, being a major pioneer in the global HMB nutrient market [4] - The company reported revenues of 947.24 million yuan, 891.89 million yuan, and 1 billion yuan for the years 2022 to 2024, with net profits of 143.04 million yuan, 153.37 million yuan, and 170.61 million yuan respectively [4]